SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-221297
Filing Date
2022-08-15
Accepted
2022-08-15 17:18:40
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d289026d10q.htm   iXBRL 10-Q 1423734
2 EX-31.1 d289026dex311.htm EX-31.1 10469
3 EX-31.2 d289026dex312.htm EX-31.2 10488
4 EX-32.1 d289026dex321.htm EX-32.1 4655
5 EX-32.2 d289026dex322.htm EX-32.2 4669
  Complete submission text file 0001193125-22-221297.txt   5672134

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA abos-20220630.xsd EX-101.SCH 45692
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abos-20220630_cal.xml EX-101.CAL 38584
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abos-20220630_def.xml EX-101.DEF 219306
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abos-20220630_lab.xml EX-101.LAB 325672
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abos-20220630_pre.xml EX-101.PRE 273745
53 EXTRACTED XBRL INSTANCE DOCUMENT d289026d10q_htm.xml XML 992615
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 221166763
SIC: 2836 Biological Products, (No Diagnostic Substances)